ARROWHEAD PHARMACEUTICALS, INC. Equity Method Investments
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Equity Method Investments of $1.48 million as of 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net › Long-Term Investments
us-gaap:EquityMethodInvestments · last filed 2012-12-28
- 2012-03-31: Equity Method Investments $1.48M.
- 2011-12-31: Equity Method Investments $1.54M.
- 2011-09-30: Equity Method Investments $1.65M.
- 2011-06-30: Equity Method Investments $1.72M.
| Period end | Equity Method Investments |
|---|---|
| 2012-03-31 | $1.48M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $1.54M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $1.65M 10-K · filed 2012-12-28 |
| 2011-06-30 | $1.72M 10-Q · filed 2011-08-08 |
| 2010-09-30 | $1.81M 10-K · filed 2011-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |